Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

2.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

3.

[AML(M7) associated with t(16;21)(p11;q22) showing relapse after unrelated bone marrow transplantation and disappearance of TLS/FUS-ERG mRNA].

Fukushima Y, Fujii N, Tabata Y, Nishimura Y, Fusaoka T, Yoshihara T, Tsunamoto K, Kasubuchi Y, Morimoto A, Hibi S, Taketani K, Hayashi Y, Imashuku S.

Rinsho Ketsueki. 2001 Jun;42(6):502-6. Review. Japanese.

PMID:
11505530
4.

Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.

Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S31-4. Review.

PMID:
11587363
5.

The emerging molecular genetics of sarcoma translocations.

Ladanyi M.

Diagn Mol Pathol. 1995 Sep;4(3):162-73. Review.

PMID:
7493135
6.

TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.

Ron D.

Curr Top Microbiol Immunol. 1997;220:131-42. Review. No abstract available.

PMID:
9103679
7.

[FUS/TLS as a polyglutamine aggregate interacting protein].

Nukina N.

Rinsho Shinkeigaku. 2010 Nov;50(11):945-7. Review. Japanese.

PMID:
21921521
8.

[Current idea of the morphogenetic features of liposarcomas].

Todorov SS, Kit OI.

Arkh Patol. 2012 Nov-Dec;74(6):61-3. Review. Russian.

PMID:
23383449
Items per page

Supplemental Content

Support Center